These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 4688175)

  • 21. Psychoactive compounds and audiogenic seizure susceptibility.
    Boggan WO
    Life Sci; 1973 Jul; 13(2):151-9. PubMed ID: 4751412
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 23. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 24. [Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].
    Alekseeva LA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1969; 19(2):279-85. PubMed ID: 5404353
    [No Abstract]   [Full Text] [Related]  

  • 25. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analysis of some discriminative properties of d-amphetamine.
    Kuhn DM; Appel JB; Greenberg I
    Psychopharmacologia; 1974; 39(1):57-66. PubMed ID: 4138622
    [No Abstract]   [Full Text] [Related]  

  • 27. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE; Kanter SL; Dronkert A
    Behav Neuropsychiatry; 1970; 2(3):50-4. PubMed ID: 4913153
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of behavior maintained by intravenous cocaine and d-amphetamine in dogs.
    Shannon HE; Risner ME
    J Pharmacol Exp Ther; 1984 May; 229(2):422-32. PubMed ID: 6716267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of intraocular mescaline and LSD on visual-evoked responses in the rat.
    Eells JT; Wilkison DM
    Pharmacol Biochem Behav; 1989 Jan; 32(1):191-6. PubMed ID: 2734330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSD and fixed-internal responding in the rat.
    Altman JL; Appel JB
    Pharmacol Biochem Behav; 1975; 3(2):151-5. PubMed ID: 1144475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of d- and l- amphetamine on fixed-interval and fixed-ratio behavior in tolerant and nontolerant rats.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):372-9. PubMed ID: 4748553
    [No Abstract]   [Full Text] [Related]  

  • 34. [Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
    VOJTECHOVSKY M; GROF S
    Cesk Psychiatr; 1960 Aug; 56():221-33. PubMed ID: 13781932
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of lysergic acid diethylamide (LSD-25) upon conditioning and sweating].
    Sivadjian J
    Therapie; 1970; 25(4):813-21. PubMed ID: 5458924
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT
    AMA Arch Ophthalmol; 1958 May; 59(5):722-30. PubMed ID: 13519998
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative action of mescaline, LSD 25 and yageine on the central temperature of the rat].
    DELPHAUT J; LANZA M
    J Physiol (Paris); 1960; 52():70-1. PubMed ID: 13815749
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX; AGHAJANIAN GK; ORNITZ EM
    Science; 1958 May; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract]   [Full Text] [Related]  

  • 40. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.